Literature DB >> 12054905

Identification and characterization of transcription factor target genes using gene-targeted mice.

Deborah DeRyckere1, James DeGregori.   

Abstract

Critical to understanding biological roles for transcription factors is an appreciation of the target genes regulated by the transcription factor. The identification of target genes can often expand the understanding of known biological roles for a transcription factor and may reveal unappreciated and unexpected functions. This article focuses on the identification and characterization of transcription factor target genes using mouse molecular genetics. The use of genetically engineered (knockout) mice and global gene expression analysis to identify transcription factor target genes is reviewed, with emphasis on important technical considerations. Detailed protocols for the application of real-time reverse transcription polymerase chain reaction and immunohistochemistry in target gene expression analysis are described. The article closes with a discussion of the use of mouse molecular genetics for the characterization of target genes as downstream effectors of transcription factors. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054905     DOI: 10.1016/S1046-2023(02)00008-7

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  4 in total

1.  MDM2 is required for suppression of apoptosis by activated Akt1 in salivary acinar cells.

Authors:  Kirsten H Limesand; Kathryn L Schwertfeger; Steven M Anderson
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

2.  The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss.

Authors:  Feng X Li; Jing W Zhu; Jeffery S Tessem; Joshua Beilke; Marileila Varella-Garcia; Jan Jensen; Christopher J Hogan; James DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

3.  Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia.

Authors:  Rachel M A Linger; Alisa B Lee-Sherick; Deborah DeRyckere; Rebecca A Cohen; Kristen M Jacobsen; Amy McGranahan; Luis N Brandão; Amanda Winges; Kelly K Sawczyn; Xiayuan Liang; Amy K Keating; Aik Choon Tan; H Shelton Earp; Douglas K Graham
Journal:  Blood       Date:  2013-07-16       Impact factor: 22.113

4.  Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.

Authors:  Rachel M A Linger; Deborah DeRyckere; Luis Brandão; Kelly K Sawczyn; Kristen M Jacobsen; Xiayuan Liang; Amy K Keating; Douglas K Graham
Journal:  Blood       Date:  2009-07-30       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.